These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1796930)

  • 1. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 4th communication: disposition of zinc and amino acids in rats, dogs and monkeys.
    Furuta S; Toyama S; Miwa M; Ikeda Y; Sano H; Matsuda K
    Arzneimittelforschung; 1991 Sep; 41(9):992-5. PubMed ID: 1796930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 2nd communication: absorption, distribution, metabolism and excretion after repeated administration to rats.
    Toyama S; Furuta S; Miwa M; Suzuki M; Sano H; Matsuda K
    Arzneimittelforschung; 1991 Sep; 41(9):976-83. PubMed ID: 1796928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
    Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
    Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the metabolic fate of catena-(S)-[mu-N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 3rd communication: transfer into fetus and milk in rats.
    Toyama S; Furuta S; Miwa M; Suzuki M; Sano H; Matsuda K
    Arzneimittelforschung; 1991 Sep; 41(9):984-91. PubMed ID: 1796929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
    Shibata K; Matsuda K; Wada H; Aruga F; Yamada Y
    Arzneimittelforschung; 1991 Oct; 41(10):1048-52. PubMed ID: 1799382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc].
    Shibata K; Matsuda K; Ohta T; Sasaki Y; Sutou S
    Arzneimittelforschung; 1991 Oct; 41(10):1053-7. PubMed ID: 1799383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of the novel anti-peptic ulcer agent catena-(S)-[mu-[Na- (3-aminopropionyl)histidinato(2-)-N1,N2,Q:N tau]-zinc in male cynomolgus monkeys.
    Green OP; Deoraj P; Gopinath C; Crook D; Matsuda K
    Arzneimittelforschung; 1993 May; 43(5):562-9. PubMed ID: 8329001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose toxicity study on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc] in mice and rats.
    Matsuda K; Shibata K; Morikami H; Kato T; Aruga F
    Arzneimittelforschung; 1991 Oct; 41(10):1033-5. PubMed ID: 1799379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive and developmental toxicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc].
    Matsuda K; Nishi N; Hiramatsu Y; Shimizu M; Ohta T; Kato M
    Arzneimittelforschung; 1991 Oct; 41(10):1042-8. PubMed ID: 1799381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated dose toxicity studies on catena-(S)-[mu-[N alpha-(3-aminopropionyl) histidinato(2-)-N1,N2,O:N tau]-zinc] in rats.
    Matsuda K; Mera Y; Wada H; Aruga H; Saik Y; Taniguchi Y
    Arzneimittelforschung; 1991 Oct; 41(10):1036-41. PubMed ID: 1799380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of the novel anti-peptic ulcer agent polaprezinc in beagle dogs.
    Matsuda K; Yamaguchi I; Wada H
    Arzneimittelforschung; 1995 Jan; 45(1):52-60. PubMed ID: 7893270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of polaprezinc in rats determined by the double tracer method.
    Furuta S; Suzuki M; Toyama S; Miwa M; Sano H
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):453-61. PubMed ID: 10704111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.